SANOFI INDIA
|
The Current P/S Ratio of SANOFI INDIA is 3.81.
| Share Price | ₹2,991.2 | Oct 28,2026 |
| Market Cap | ₹6,879.6 Cr | |
| Sales-TTM | ₹1,805.2 Cr | TTM-Standalone Results |
| Price/Sales | 3.81x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of SANOFI INDIA
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹6,879.6 Cr] as on Oct 28,2026
(/) Sales [ ₹1,805.2 Cr] based on TTM-Standalone Results
(=) P/S Ratio [ 3.81x ]
Thus, for SANOFI INDIA , the investors are currently willing to pay '3.81 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of SANOFI INDIA !
The chart below summarizes the trend in P/S Ratio of SANOFI INDIA over the last five years.
Historical PS (Price/Sales) ratio chart of SANOFI INDIA
PS Ratio Performance Analysis for SANOFI INDIA
- SANOFI INDIA 's p/e ratio for fiscal years ending Dec2025 to Dec2021 averaged 6.48x.
- SANOFI INDIA 's operated at median p/e ratio of 6.14x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, SANOFI INDIA 's p/e ratio peaked in Dec2023 at 9.3x.
- SANOFI INDIA 's p/e ratio hit its five-year low in Dec2022 of 4.86x.
How does SANOFI INDIA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| SANOFI INDIA | 1,805.2 | 3.81 | 6,879.6 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 59,910.5 | 7.04 | 421,803.0 |
| DIVIS LABORATORIES LTD | 11,230.0 | 22.60 | 253,833.0 |
| TORRENT PHARMACEUTICALS LTD | 17,400.0 | 9.97 | 173,461.0 |
| CIPLA LTD | 28,138.9 | 3.90 | 109,870.0 |
| DR REDDYS LABORATORIES LTD | 33,097.4 | 3.37 | 111,463.0 |
| MANKIND PHARMA LTD | 15,378.6 | 6.67 | 102,584.0 |
| LUPIN LTD | 29,966.6 | 3.01 | 90,132.5 |
| ZYDUS LIFESCIENCES LTD | 28,591.7 | 4.09 | 116,907.0 |
| AUROBINDO PHARMA LTD | 34,935.3 | 2.70 | 94,367.7 |
| LAURUS LABS LTD | 7,269.6 | 16.24 | 118,056.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs SANOFI INDIA 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.70x |
| Max industry PS | 22.60x |
| Median industry PS | 4.09x |
| Average industry PS | 7.58x |
You may also like the below Video Courses